C22H25N3O2
Neat
363.46
Baxdrostat; Baxdrostat [INN]; CIN-107; NF3P9Z8J5Y; RO6836191; CIN107; (+)-(R)-N-(4-(1-Methyl-2-oxo-1, 2, 3, 4-tetrahydroquinolin-6-yl)-5, 6, 7, 8-tetrahydroisoquinolin-8-yl)propionamide; N-[(8R)-4-(1-methyl-2-oxo-3, 4-dihydroquinolin-6-yl)-5, 6, 7, 8-tetrahydroisoquinolin-8-yl]propanamide; N-((8R)-5, 6, 7, 8-Tetrahydro-4-(1, 2, 3, 4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)propanamide; Propanamide, N-((8R)-5, 6, 7, 8-tetrahydro-4-(1, 2, 3, 4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)-; N-((8R)-4-(1-methyl-2-oxo-3, 4-dihydroquinolin-6-yl)-5, 6, 7, 8-tetrahydroisoquinolin-8-yl)propanamide; Propanamide, N-[(8R)-5, 6, 7, 8-tetrahydro-4-(1, 2, 3, 4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl]-; RefChem:116708; 894-447-6; 1428652-17-8; UNII-NF3P9Z8J5Y; RO-6836191; Baxdrostat?; BAXDROSTAT [USAN]; N-[(8R)-4-(1-methyl-2-oxo-1, 2, 3, 4-tetrahydroquinolin-6-yl)-5, 6, 7 and 8-tetrahydroisoquinolin-8-yl]propanamide
N-[(8R)-4-(1-methyl-2-oxo-3, 4-dihydroquinolin-6-yl)-5, 6, 7 and 8-tetrahydroisoquinolin-8-yl]propanamide
InChI=1S/C22H25N3O2/c1-3-21(26)24-19-6-4-5-16-17(12-23-13-18(16)19)14-7-9-20-15(11-14)8-10-22(27)25(20)2/h7,9,11-13,19H,3-6,8,10H2,1-2H3,(H,24,26)/t19-/m1/s1